Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Peptic Ulcer

  Free Subscription


Articles published in Eur J Gastroenterol Hepatol

Retrieve available abstracts of 29 articles:
HTML format
Text format



Single Articles


    September 2018
  1. WILKINSON J, Wade A, Thomas SJ, Jenner B, et al
    Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.
    Eur J Gastroenterol Hepatol. 2018 Sep 27. doi: 10.1097/MEG.0000000000001258.
    PubMed     Text format     Abstract available


    July 2018
  2. ISLAM MM, Poly TN, Walther BA, Dubey NK, et al
    Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2018 Jul 19. doi: 10.1097/MEG.0000000000001198.
    PubMed     Text format     Abstract available


  3. JARUVONGVANICH V, Poonsombudlert K, Ungprasert P
    Vonoprazan versus proton-pump inhibitors for gastric endoscopic submucosal dissection-induced ulcers: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2018 Jul 6. doi: 10.1097/MEG.0000000000001204.
    PubMed     Text format     Abstract available


    June 2018
  4. TALEBI BEZMIN ABADI A, Yamaoka Y
    Call for shift in Helicobacter pylori treatment.
    Eur J Gastroenterol Hepatol. 2018;30:687.
    PubMed     Text format    


    April 2018
  5. PONZETTO A, Figura N
    Helicobacter pylori infection among patients with liver cirrhosis.
    Eur J Gastroenterol Hepatol. 2018;30:490.
    PubMed     Text format    


    March 2018
  6. KHAN MY, Siddiqui WJ, Alvarez C, Aggarwal S, et al
    Reduction in postpercutaneous coronary intervention angina in addition to gastrointestinal events in patients on combined proton pump inhibitors and dual antiplatelet therapy: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2018 Mar 28. doi: 10.1097/MEG.0000000000001125.
    PubMed     Text format     Abstract available


  7. PELLICANO R, Durazzo M
    Helicobacter pylori among patients with uninvestigated dyspepsia: issues to be remembered.
    Eur J Gastroenterol Hepatol. 2018;30:278-279.
    PubMed     Text format    


    February 2018
  8. FIORINI G, Zullo A, Saracino IM, Gatta L, et al
    Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice.
    Eur J Gastroenterol Hepatol. 2018 Feb 23. doi: 10.1097/MEG.0000000000001102.
    PubMed     Text format     Abstract available


  9. XAVIER SA, Vilas-Boas R, Boal Carvalho P, Magalhaes JT, et al
    Assessment of prognostic performance of Albumin-Bilirubin, Child-Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding.
    Eur J Gastroenterol Hepatol. 2018 Feb 12. doi: 10.1097/MEG.0000000000001087.
    PubMed     Text format     Abstract available


    November 2017
  10. SUKI M, Leibovici Weissman Y, Boltin D, Itskoviz D, et al
    Helicobacter pylori infection is positively associated with an increased BMI, irrespective of socioeconomic status and other confounders: a cohort study.
    Eur J Gastroenterol Hepatol. 2017 Nov 8. doi: 10.1097/MEG.0000000000001014.
    PubMed     Text format     Abstract available


  11. PELLICANO R
    Helicobacter pylori among patients with cirrhosis: incidence or prevalence?
    Eur J Gastroenterol Hepatol. 2017;29:1315.
    PubMed     Text format    


    September 2017
  12. BARAN M, Cagan Appak Y, Karakoyun M, Yalcinkaya S, et al
    The overlap of gastroesophageal reflux disease and functional constipation in children: the efficacy of constipation treatment.
    Eur J Gastroenterol Hepatol. 2017 Sep 13. doi: 10.1097/MEG.0000000000000979.
    PubMed     Text format     Abstract available


  13. COSTA S, Soares JB, Goncalves R
    Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection.
    Eur J Gastroenterol Hepatol. 2017 Sep 4. doi: 10.1097/MEG.0000000000000960.
    PubMed     Text format     Abstract available


    August 2017
  14. MALMI H, Kautiainen H, Virta LJ, Farkkila MA, et al
    Outcomes of patients hospitalized with peptic ulcer disease diagnosed in acute upper endoscopy.
    Eur J Gastroenterol Hepatol. 2017 Aug 29. doi: 10.1097/MEG.0000000000000951.
    PubMed     Text format     Abstract available


  15. SIECZKOWSKA A, Landowski P, Zagozdzon P, Kaminska B, et al
    The association of proton pump inhibitor therapy and small bowel bacterial overgrowth in children.
    Eur J Gastroenterol Hepatol. 2017 Aug 10. doi: 10.1097/MEG.0000000000000946.
    PubMed     Text format    


    July 2017
  16. ZHOU YJ, Zheng JN, Zhou YF, Han YJ, et al
    Development of a prognostic nomogram for cirrhotic patients with upper gastrointestinal bleeding.
    Eur J Gastroenterol Hepatol. 2017 Jul 25. doi: 10.1097/MEG.0000000000000943.
    PubMed     Text format     Abstract available


  17. POGORZELSKA J, Lapinska M, Kalinowska A, Lapinski TW, et al
    Helicobacter pylori infection among patients with liver cirrhosis.
    Eur J Gastroenterol Hepatol. 2017 Jul 11. doi: 10.1097/MEG.0000000000000928.
    PubMed     Text format     Abstract available


  18. JENSEN BES, Hansen JM, Larsen KS, Junker AB, et al
    Randomized clinical trial: the impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy.
    Eur J Gastroenterol Hepatol. 2017 Jul 3. doi: 10.1097/MEG.0000000000000934.
    PubMed     Text format     Abstract available


    June 2017
  19. VIAZIS N, Katopodi K, Karamanolis G, Denaxas K, et al
    Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain.
    Eur J Gastroenterol Hepatol. 2017 Jun 16. doi: 10.1097/MEG.0000000000000925.
    PubMed     Text format     Abstract available


    May 2017
  20. FILL MALFERTHEINER S, Seelbach-Gobel B, Costa SD, Ernst W, et al
    Impact of gastroesophageal reflux disease symptoms on the quality of life in pregnant women: a prospective study.
    Eur J Gastroenterol Hepatol. 2017 May 3. doi: 10.1097/MEG.0000000000000905.
    PubMed     Text format     Abstract available


  21. SMITH S, Boyle B, Brennan D, Buckley M, et al
    The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.
    Eur J Gastroenterol Hepatol. 2017;29:552-559.
    PubMed     Text format     Abstract available


    April 2017
  22. PELLICANO R, Fagoonee S
    Any role for proton pump inhibitors in the relationship between new erosive oesophagitis and abdominal visceral fat?
    Eur J Gastroenterol Hepatol. 2017;29:489.
    PubMed     Text format    


  23. NAM SY, Kim YW, Park BJ, Ryu KH, et al
    Effect of abdominal visceral fat on the development of new erosive oesophagitis: a prospective cohort study.
    Eur J Gastroenterol Hepatol. 2017;29:388-395.
    PubMed     Text format     Abstract available


    February 2017
  24. ROYSTON C, Bardhan KD
    Adam, Eve and the reflux enigma: age and sex differences across the gastro-oesophageal reflux spectrum.
    Eur J Gastroenterol Hepatol. 2017 Feb 1. doi: 10.1097/MEG.0000000000000845.
    PubMed     Text format     Abstract available


    January 2017
  25. SMITH S, Boyle B, Brennan D, Buckley M, et al
    The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.
    Eur J Gastroenterol Hepatol. 2017 Jan 10. doi: 10.1097/MEG.0000000000000822.
    PubMed     Text format     Abstract available


    December 2016
  26. CARES K, Al-Ansari N, Macha S, Zoubi N, et al
    Risk of small intestinal bacterial overgrowth with chronic use of proton pump inhibitors in children.
    Eur J Gastroenterol Hepatol. 2016 Dec 27. doi: 10.1097/MEG.0000000000000815.
    PubMed     Text format     Abstract available


    November 2016
  27. UPALA S, Sanguankeo A, Saleem SA, Jaruvongvanich V, et al
    Effects of Helicobacter pylori eradication on insulin resistance and metabolic parameters: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  28. STROMDAHL M, Helgeson J, Kalaitzakis E
    Emergency readmission following acute upper gastrointestinal bleeding.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  29. JEE SR, Park MI, Lim SK, Kim SE, et al
    Clinical impact of second-look endoscopy after endoscopic submucosal dissection of gastric neoplasm: a multicenter prospective randomized-controlled trial.
    Eur J Gastroenterol Hepatol. 2016;28:546-52.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: